Product Name: LAMTOR1 antibody
Applications: WB
Predicted Target Size: 18 kDa (note)
Positive Controls: HeLa , SKNSH
Form Supplied: Liquid
Concentration: 0.69 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: late endosomal/lysosomal adaptor, MAPK and MTOR activator 1
Background: Activates RHOA. Binds to CDKN1B and prevents interaction of CDKN1B and RHOA. This leaves RHOA in a form accessible to ARHGEF2, thereby promoting ARHGEF2-mediated exchange of GDP for GTP.
Synonyms: C11orf59 antibody , PDRO antibody , Ragulator1 antibody , late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 antibody , p18 antibody , p27RF Rho antibody
Cellular Localization:
CAS NO: 15826-37-6
Product: Efonidipine (hydrochloride monoethanolate)
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Full length human LAMTOR1 recombinant protein.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 1XPBS, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/25390651?dopt=Abstract
